## **Core Concept**
Preventive chemotherapy for tuberculosis (TB) contacts, also known as latent TB infection (LTBI) treatment, targets individuals at high risk of progressing to active TB disease. This strategy is crucial for controlling TB transmission, especially among close contacts of sputum-positive pulmonary TB patients.

## **Why the Correct Answer is Right**
The correct answer focuses on individuals who are at a higher risk of developing active TB disease if infected. This typically includes:
- Children under 5 years old, due to their immature immune systems.
- Individuals with compromised immune systems, such as those with HIV/AIDS, undergoing chemotherapy, or on long-term corticosteroid therapy.
- Close contacts of sputum-positive TB patients are prioritized because of the high bacillary load and thus higher transmission risk.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might not specifically target the highest-risk groups or might be too broad without specifying age or immune status.
- **Option B:** Similarly, this could be incorrect if it doesn't prioritize those under 5 or those with significant immunosuppression.
- **Option D:** This option might not accurately reflect the most vulnerable groups or could omit critical populations like young children or immunocompromised individuals.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the **Mantoux tuberculin skin test (TST)** and **interferon-gamma release assays (IGRAs)** are used to diagnose latent TB infection. High-risk contacts, especially children under 5 and immunocompromised individuals, should be tested and treated promptly to prevent progression to active TB disease.

## **Correct Answer:** .